Is CCCC a good stock to buy? C4 Therapeutics, Inc. (NASDAQ:CCCC) was in 20 hedge funds' portfolios at the end of March. The all time high for this statistic is 22. CCCC investors should pay attention ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

C4 Therapeutics' partnership with Merck has doubled the company's share price, but it is important to be aware of what this collaboration entails. Positive early clinical data for C4 Therapeutics' ...

Investors are always looking for stocks that are poised to beat at earnings season and C4 Therapeutics, Inc. CCCC, may be one such company. The firm has earnings coming up pretty soon, and events are ...